Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation

被引:101
|
作者
Zhang, Jian [1 ]
Chen, Chu [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA
关键词
D O I
10.1074/jbc.M800524200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endocannabinoids are involved in synaptic signaling and neuronal protection; however, our understanding of the mechanisms by which endocannabinoids protect neurons from harmful insults remains elusive. 2-Arachidonoylglycerol (2-AG), the most abundant endogenous cannabinoid and a full agonist for cannabinoid receptors (CB1 and CB2), is a substrate for cyclooxygenase-2 (COX-2) and can be metabolized by COX-2. Here we show, however, that 2-AG is also capable of suppressing elevation of hippocampal COX-2 expression in response to proinflammatory and excitotoxic stimuli. 2-AG prevents neurodegeneration from toxic assaults that elevate COX-2 expression and inhibits the COX-2 elevation-enhanced excitatory glutamatergic synaptic transmission. The action of 2-AG on suppression of COX-2 appeared to be mediated via the pertussis toxin-sensitive G protein-coupled CB1 receptor and MAPK/NF-kappa B signaling pathways. Our results reveal that 2-AG functions as an endogenous COX-2 inhibitor protecting neurons from harmful insults by preventing excessive expression of COX-2, which provides a mechanistic basis for opening up new therapeutic approaches for protecting neurons from inflammation-and excitotoxicity-induced neurodegeneration.
引用
收藏
页码:22601 / 22611
页数:11
相关论文
共 50 条
  • [1] Endocannabinoid 2-AG protects neurons by limiting COX-2 elevation
    Zhang, J.
    Chen, C.
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 : 26 - 26
  • [2] ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL PROTECTS NEURONS AGAINST β-AMYLOID INSULTS
    Chen, X.
    Zhang, J.
    Chen, C.
    NEUROSCIENCE, 2011, 178 : 159 - 168
  • [3] Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ
    Du, Huizhi
    Chen, Xiaolei
    Zhang, Jian
    Chen, Chu
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (07) : 1533 - 1549
  • [4] Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol
    Ueda, Natsuo
    Tsuboi, Kazuhito
    Uyama, Toru
    Ohnishi, Taira
    BIOFACTORS, 2011, 37 (01) : 1 - 7
  • [5] Tetrahydrolipstatin Analogues as Modulators of Endocannabinoid 2-Arachidonoylglycerol Metabolism
    Ortar, Giorgio
    Bisogno, Tiziana
    Ligresti, Alessia
    Morera, Enrico
    Nalli, Marianna
    Di Marzo, Vincenzo
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) : 6970 - 6979
  • [6] The endocannabinoid 2-arachidonoylglycerol regulates platelet function.
    Baldassarri, Samantha
    Bertoni, Alessandra
    Lova, Paolo
    Reineri, Stefania
    Sarasso, Chiara
    Zanfa, Manuela
    Sanna, Elena
    Maccarrone, Mauro
    Torti, Mauro
    Sinigaglia, Fabiola
    BLOOD, 2006, 108 (11) : 53B - 53B
  • [7] The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair
    Jehle, Julian
    Eich, Lukas
    Danisch, Melina
    Bagheri, Sayeh
    Avraamidou, Elina
    Pfeifer, Philipp
    Tiyerili, Vedat
    Bindila, Laura
    Lutz, Beat
    Nickenig, Georg
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 323 : 243 - 250
  • [8] Blockade of β-cell KATP channels by the endocannabinoid, 2-arachidonoylglycerol
    Spivak, Charles E.
    Kim, Wook
    Liu, Qing-Rong
    Lupica, Carl R.
    Doyle, Maire E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 423 (01) : 13 - 18
  • [9] Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-Arachidonoylglycerol
    Hanlon, E. C.
    Tasali, E.
    Leproult, R.
    Stuhr, K. L.
    Doncheck, E.
    de Wit, H.
    Hillard, C. J.
    Van Cauter, E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (01): : 220 - 226
  • [10] Mechanisms of endothelial cell activation by endocannabinoid 2-arachidonoylglycerol
    Jehle, J.
    Eich, L.
    Avraamidou, E.
    Tiyerili, V
    Bindila, L.
    Lutz, B.
    Nickenig, G.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3744 - 3744